Eurofins Biolab Srl
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Italy
- Registered address
- Via Bruno Buozzi 2, Vimodrone, Milano 20055, Italy (ITA)
- Operations here
- analysis
- FDA identifiers
- FEI 3002806530 · DUNS 429117112
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-09-13
- VAIDrug Quality Assurance2018-10-05
- VAIDrug Quality Assurance2018-04-18
- VAIDrug Quality Assurance2015-05-21
- NAIDrug Quality Assurance2009-05-20
Drugs this plant is listed as making
10 distinct drugs across 19 products name this site in their FDA label.
- anakinraSwedish Orphan Biovitrum AB (publ)
- dantrolene sodiumUswm, Llc
- DaratumumabJanssen Biotech, Inc.
- doxorubicin hydrochlorideBaxter Healthcare Corporation
- gemcitabine intravesicalJanssen Biotech, Inc
- minocycline hydrochlorideMelinta Therapeutics, LLC
- nipocalimab-aahuJanssen Biotech, Inc.
- talazoparibPfizer Laboratories Div Pfizer Inc
- ThiotepaAmneal Pharmaceuticals LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.